Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RBY | Runners | 12/01/16 | 2 | 2.3K | |||
|
|||||||
RBY | communication | 21/06/13 | 0 | 632 | |||
|
|||||||
RBY | selling | 19/12/11 | 0 | 714 | |||
|
|||||||
RBY | where to get info | 28/01/11 | 7 | 3.1K | |||
|
|||||||
RBY | Ann: Removal from Official List | 29/01/10 | 1 | 1.2K | |||
|
|||||||
RBY | article - singapore news | 19/12/09 | 4 | 2.0K | |||
|
|||||||
RBY | Ann: Update on Intention to delist | 02/12/09 | 0 | 877 | |||
|
|||||||
RBY | Ann: Results of Meeting | 30/11/09 | 0 | 902 | |||
|
See All Discussions